Last updated: September 26, 2024
Sponsor: Myasthenia Gravis Foundation of America
Overall Status: Active - Recruiting
Phase
N/A
Condition
Myasthenia Gravis Generalised
Carcinoma
Polymyositis (Inflammatory Muscle Disease)
Treatment
N/AClinical Study ID
NCT06617741
X130401004
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
age over 18
positive MG diagnosis
Exclusion
Exclusion Criteria:
age under 18
misdiagnosed with MG
Study Design
Total Participants: 3800
Study Start date:
October 12, 2013
Estimated Completion Date:
September 19, 2029
Study Description
Connect with a study center
Myasthenia Gravis Foundation of America
Westborough, Massachusetts 01581
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.